Vinva Investment Management Ltd acquired a new stake in shares of Healthpeak Properties, Inc. (NYSE:DOC - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 31,177 shares of the real estate investment trust's stock, valued at approximately $623,000.
A number of other hedge funds have also recently modified their holdings of the business. Avior Wealth Management LLC bought a new position in Healthpeak Properties in the 3rd quarter worth about $37,000. Groupama Asset Managment bought a new position in shares of Healthpeak Properties in the third quarter worth approximately $37,000. Wiser Advisor Group LLC purchased a new stake in shares of Healthpeak Properties during the third quarter valued at approximately $42,000. Continuum Advisory LLC bought a new stake in shares of Healthpeak Properties during the third quarter valued at approximately $44,000. Finally, AdvisorNet Financial Inc raised its holdings in Healthpeak Properties by 34.5% in the 4th quarter. AdvisorNet Financial Inc now owns 2,193 shares of the real estate investment trust's stock worth $44,000 after acquiring an additional 563 shares during the last quarter. Institutional investors own 93.57% of the company's stock.
Analysts Set New Price Targets
DOC has been the topic of several recent analyst reports. Morgan Stanley upgraded Healthpeak Properties from an "equal weight" rating to an "overweight" rating and set a $25.00 target price on the stock in a research note on Wednesday, January 15th. Wedbush dropped their price objective on Healthpeak Properties from $27.00 to $24.00 and set an "outperform" rating on the stock in a research report on Friday, February 14th. StockNews.com raised Healthpeak Properties from a "sell" rating to a "hold" rating in a research report on Saturday. Scotiabank dropped their price target on shares of Healthpeak Properties from $24.00 to $23.00 and set a "sector outperform" rating on the stock in a report on Friday, February 28th. Finally, Robert W. Baird reduced their price target on shares of Healthpeak Properties from $25.00 to $24.00 and set an "outperform" rating for the company in a research note on Tuesday, February 11th. Four equities research analysts have rated the stock with a hold rating, ten have issued a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $23.92.
Read Our Latest Stock Analysis on Healthpeak Properties
Healthpeak Properties Stock Performance
NYSE:DOC traded up $0.16 during mid-day trading on Wednesday, hitting $20.32. 3,661,246 shares of the company traded hands, compared to its average volume of 4,624,604. The company has a quick ratio of 1.35, a current ratio of 1.35 and a debt-to-equity ratio of 0.96. The stock's fifty day moving average price is $20.25 and its 200-day moving average price is $21.14. The firm has a market cap of $14.21 billion, a price-to-earnings ratio of 58.04, a price-to-earnings-growth ratio of 2.17 and a beta of 1.14. Healthpeak Properties, Inc. has a one year low of $17.51 and a one year high of $23.26.
Healthpeak Properties Increases Dividend
The company also recently announced a quarterly dividend, which was paid on Wednesday, February 26th. Shareholders of record on Friday, February 14th were paid a dividend of $0.305 per share. This is a boost from Healthpeak Properties's previous quarterly dividend of $0.30. The ex-dividend date was Friday, February 14th. This represents a $1.22 dividend on an annualized basis and a yield of 6.01%. Healthpeak Properties's dividend payout ratio (DPR) is presently 348.57%.
Healthpeak Properties Company Profile
(
Free Report)
Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
Further Reading

Before you consider Healthpeak Properties, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthpeak Properties wasn't on the list.
While Healthpeak Properties currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.